[at Bloomberg] - When 100 of the top lung doctors in the U.S. gathered at a Hilton hotel in Houston last month to learn about GlaxoSmithKline Plc's new respiratory drug, one message rang loud and clear: don't ignore the ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment